Results 76 - 89 from 89 for "biofarm"
-
Biofarm Proposes 30% Higher Dividend For 2012
03.14.2013
The managing board of Romanian drug maker Biofarm (BIO.RO) Thursday proposed paying out its shareholders dividends of 14.2 million lei (EUR3.2 million) from the profit registered in 2012, up 30% on more
-
Biofarm 2012 Net Profit Up 48% To RON21M
02.15.2013
Romanian drugmaker Biofarm (BIO.RO) Friday said its net profit rose 48% to 21.04 million lei (EUR4.8 million) in 2012, boosted by a 12.3% increase in sales. more
-
Biofarm Net Profit Rises To RON17.3M In January-September
11.14.2012
Romanian drugmaker Biofarm (BIO.RO) Monday said its net profit rose 26.2% to 17.35 million lei (EUR3.9 million) in the first nine months, helped by higher sales. more
-
Biofarm 1H Profit Up 11% To RON12M
08.14.2012
Romanian drugmaker Biofarm (BIO.RO) Tuesday said its net profit in the first half of the year grew by 11.4%, to 12.27 million (EUR2.8 million). more
-
Biofarm 1Q Net Profit Up 8% To RON8.2M
05.14.2012
Romanian drugmaker Biofarm (BIO.RO) Monday said its net profit rose 8.1% to 8.2 million lei (EUR1.85 million) in the first quarter, as costs decreased faster than revenues. more
-
Biofarm Sees 2012 Net Profit Up 17% To RON16.6M
04.24.2012
Romanian drugmaker Biofarm (BIO.RO) estimates its net profit will rise 17% on the year to 16.6 million lei (EUR3.79 million) in 2012, fueled by higher sales. more
-
Biofarm Set To Double Dividend
03.20.2012
Romanian drugmaker Biofarm (BIO.RO) Tuesday proposed paying out a gross dividend of 0.01 lei (EUR0.002) a share from the 2011 profit, nearly double of the year. more
-
Biofarm Emerges As Most Profitable Pharma Company On Bucharest Bourse
02.20.2012
Biofarm (BIO.RO) was the most profitable pharmaceuticals company on the Bucharest stock exchange last year. Despite a two-percentage point drop in net profit margin to 15.5%, the drugmaker surpassed more
-
Biofarm Posts 13.5% Hike In 2011 Sales, To RON93.4M
02.15.2012
Medicine maker Biofarm Bucuresti (BIO.RO) posted sales of 93.4 million lei (EUR21.48 million) in 2011, up 13.5% from RON82.2 million in the previous year, while profit stagnated. more
-
Biofarm 9-Mo Sales Up 12% YY To RON67.2M
11.14.2011
Sales seen between January and September by Romanian medicine maker Biofarm Bucuresti (BIO.RO) rose 12% on the year, to 67.2 million lei (EUR16 million), from RON59.7 million in the same interval of more
-
Biofarm Net Profit Rises 14.4% To RON11M In First Six Months
08.12.2011
Romanian drugmaker Biofarm (BIO.RO) Friday reported first-half net profit of 11 million lei (EUR2.56 million), on total sales of RON49.5 million, 19% higher on the year. more
-
Drug Maker Biofarm's 1Q Net Profit Rises 20% To RON6M
05.13.2011
Romanian medicine maker Biofarm (BIO.RO) on Friday reported a net profit of 6 million lei (EUR1.46 million) in January to March, up 20.4% from RON4.98 million in the same interval of 2010. more
-
Raiffeisen Raises Biofarm Target Price By 10%
04.26.2011
Raiffeisen Capital&Investment on Tuesday raised by 10% to 0.23 lei (EUR0.056) a share its 12-month target price on Romanian drugmaker Biofarm (BIO.RO), while keeping its recommendation unchanged at more
-
Romania Biofarm Sees 2011 Net Profit Up 4% At RON15M
04.20.2011
Romanian drugmaker Biofarm (BIO.RO) estimates a 4% rise in its full-year profit to 14.98 million lei (EUR1=RON4.0858) on total revenue of RON92.61 million, the company said Wednesday. more